Position in STOK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$33,175,165
+$942,852 QoQ
Shares Held
1,013,911
+2.4% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 198 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 90%
Shared 6%
None 4%
Common Shares in STOK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. STOK ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in STOK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,175,165 | 1,013,911 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $32,232,313 | 989,936 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $26,253,389 | 827,139 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $15,940,214 | 678,307 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,648,581 | 673,884 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,420,486 | 664,735 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,944,064 | 538,900 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,256,970 | 265,010 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,585,271 | 191,360 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,966,826 | 219,765 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,132,444 | 215,294 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,018,180 | 258,422 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,615,739 | 340,145 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,445,951 | 293,632 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,695,221 | 292,007 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $4,352,707 | 338,996 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,500,926 | 265,021 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,192,443 | 151,660 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,730,686 | 72,142 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,137,651 | 44,719 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,547,191 | 105,383 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $4,226,685 | 108,823 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,465,619 | 39,813 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $247,189 | 7,381 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||